VK-12

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameVK-12
Drug Alias Nameanticancer/neuroprotectant (Prana)VK-12
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer DiseaseParkinson DiseaseNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlterity Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlterity Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseParkinson DiseaseNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A